<?xml version="1.0" encoding="UTF-8"?>
<TED_EXPORT xmlns:xlink="http://www.w3.org/1999/xlink"
            xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
            xmlns="ted/R2.0.9.S02/publication"
            xmlns:n2016="ted/2016/nuts"
            xsi:schemaLocation="ted/R2.0.9.S02/publication TED_EXPORT.xsd"
            VERSION="R2.0.9.S02.E01"
            DOC_ID="073750-2018"
            EDITION="2018034">
   <TECHNICAL_SECTION>
      <RECEPTION_ID>18-072348-001</RECEPTION_ID>
      <DELETION_DATE>20180525</DELETION_DATE>
      <FORM_LG_LIST>IT </FORM_LG_LIST>
      <COMMENTS>From Convertor</COMMENTS>
   </TECHNICAL_SECTION>
   <LINKS_SECTION>
      <XML_SCHEMA_DEFINITION_LINK xlink:type="simple"
                                  xlink:href="http://ted.europa.eu"
                                  xlink:title="TED WEBSITE"/>
      <OFFICIAL_FORMS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <FORMS_LABELS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <ORIGINAL_CPV_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <ORIGINAL_NUTS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
   </LINKS_SECTION>
   <CODED_DATA_SECTION>
      <REF_OJS>
         <COLL_OJ>S</COLL_OJ>
         <NO_OJ>34</NO_OJ>
         <DATE_PUB>20180217</DATE_PUB>
      </REF_OJS>
      <NOTICE_DATA>
         <NO_DOC_OJS>2018/S 034-073750</NO_DOC_OJS>
         <URI_LIST>
            <URI_DOC LG="IT">http://ted.europa.eu/udl?uri=TED:NOTICE:073750-2018:TEXT:IT:HTML</URI_DOC>
         </URI_LIST>
         <LG_ORIG>IT</LG_ORIG>
         <ISO_COUNTRY VALUE="IT"/>
         <IA_URL_GENERAL>www.soresa.it</IA_URL_GENERAL>
         <ORIGINAL_CPV CODE="33696000">Reagents and contrast media</ORIGINAL_CPV>
         <n2016:PERFORMANCE_NUTS CODE="ITF">SUD</n2016:PERFORMANCE_NUTS>
         <n2016:PERFORMANCE_NUTS CODE="IT">ITALIA</n2016:PERFORMANCE_NUTS>
         <n2016:PERFORMANCE_NUTS CODE="ITF3">Campania</n2016:PERFORMANCE_NUTS>
         <n2016:CA_CE_NUTS CODE="ITF33">Napoli</n2016:CA_CE_NUTS>
         <n2016:TENDERER_NUTS CODE="ITC4C">Milano</n2016:TENDERER_NUTS>
         <n2016:TENDERER_NUTS CODE="ITF21">Isernia</n2016:TENDERER_NUTS>
         <n2016:TENDERER_NUTS CODE="ITF11">L’Aquila</n2016:TENDERER_NUTS>
         <n2016:TENDERER_NUTS CODE="ITI33">Macerata</n2016:TENDERER_NUTS>
         <n2016:TENDERER_NUTS CODE="ITC4A">Cremona</n2016:TENDERER_NUTS>
         <VALUES>
            <VALUE TYPE="PROCUREMENT_TOTAL" CURRENCY="EUR">42874315.14</VALUE>
         </VALUES>
         <REF_NOTICE>
            <NO_DOC_OJS>2017/S 090-176502</NO_DOC_OJS>
         </REF_NOTICE>
      </NOTICE_DATA>
      <CODIF_DATA>
         <DS_DATE_DISPATCH>20180214</DS_DATE_DISPATCH>
         <AA_AUTHORITY_TYPE CODE="8">Other</AA_AUTHORITY_TYPE>
         <TD_DOCUMENT_TYPE CODE="7">Contract award notice</TD_DOCUMENT_TYPE>
         <NC_CONTRACT_NATURE CODE="2">Supplies</NC_CONTRACT_NATURE>
         <PR_PROC CODE="1">Open procedure</PR_PROC>
         <RP_REGULATION CODE="4">European Union</RP_REGULATION>
         <TY_TYPE_BID CODE="9">Not applicable</TY_TYPE_BID>
         <AC_AWARD_CRIT CODE="3">Mixed</AC_AWARD_CRIT>
         <MA_MAIN_ACTIVITIES CODE="8">Other</MA_MAIN_ACTIVITIES>
         <HEADING>01B03</HEADING>
         <INITIATOR>01</INITIATOR>
         <DIRECTIVE VALUE="2014/24/EU"/>
      </CODIF_DATA>
   </CODED_DATA_SECTION>
   <TRANSLATION_SECTION>
      <ML_TITLES>
         <ML_TI_DOC LG="BG">
            <TI_CY>Итaлия</TI_CY>
            <TI_TOWN>Неапол</TI_TOWN>
            <TI_TEXT>
               <P>Реактиви и контрастни вещества</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="CS">
            <TI_CY>Itálie</TI_CY>
            <TI_TOWN>Neapol</TI_TOWN>
            <TI_TEXT>
               <P>Činidla a kontrastní látky</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="DA">
            <TI_CY>Italien</TI_CY>
            <TI_TOWN>Napoli</TI_TOWN>
            <TI_TEXT>
               <P>Reagenser og kontrastmidler</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="DE">
            <TI_CY>Italien</TI_CY>
            <TI_TOWN>Neapel</TI_TOWN>
            <TI_TEXT>
               <P>Reagentien und Kontrastmittel</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="EL">
            <TI_CY>Ιταλία</TI_CY>
            <TI_TOWN>Νάπολη</TI_TOWN>
            <TI_TEXT>
               <P>Αντιδραστήρια και σκιαγραφικές ουσίες</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="EN">
            <TI_CY>Italy</TI_CY>
            <TI_TOWN>Naples</TI_TOWN>
            <TI_TEXT>
               <P>Reagents and contrast media</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="ES">
            <TI_CY>Italia</TI_CY>
            <TI_TOWN>Nápoles</TI_TOWN>
            <TI_TEXT>
               <P>Reactivos y medios de contraste</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="ET">
            <TI_CY>Itaalia</TI_CY>
            <TI_TOWN>Napoli</TI_TOWN>
            <TI_TEXT>
               <P>Reaktiivid ja kontrastvahendid</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="FI">
            <TI_CY>Italia</TI_CY>
            <TI_TOWN>Napoli</TI_TOWN>
            <TI_TEXT>
               <P>Reagenssit ja varjoaineet</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="FR">
            <TI_CY>Italie</TI_CY>
            <TI_TOWN>Naples</TI_TOWN>
            <TI_TEXT>
               <P>Réactifs et produits de contraste</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="GA">
            <TI_CY>Iodáil, an</TI_CY>
            <TI_TOWN>Napoli</TI_TOWN>
            <TI_TEXT>
               <P>Reagents and contrast media</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="HR">
            <TI_CY>Italija</TI_CY>
            <TI_TOWN>Napulj</TI_TOWN>
            <TI_TEXT>
               <P>Reagensi i kontrastna sredstva</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="HU">
            <TI_CY>Olaszország</TI_CY>
            <TI_TOWN>Nápoly</TI_TOWN>
            <TI_TEXT>
               <P>Reagensek és kontrasztanyagok</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="IT">
            <TI_CY>Italia</TI_CY>
            <TI_TOWN>Napoli</TI_TOWN>
            <TI_TEXT>
               <P>Reagenti e mezzi di contrasto</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="LT">
            <TI_CY>Italija</TI_CY>
            <TI_TOWN>Neapolis</TI_TOWN>
            <TI_TEXT>
               <P>Reagentai ir kontrastiniai preparatai</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="LV">
            <TI_CY>Itāija</TI_CY>
            <TI_TOWN>Neapole</TI_TOWN>
            <TI_TEXT>
               <P>Reaģenti un kontrastvielas</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="MT">
            <TI_CY>l-Italja</TI_CY>
            <TI_TOWN>Napli</TI_TOWN>
            <TI_TEXT>
               <P>Reaġenti u medja kontrastanti</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="NL">
            <TI_CY>Italië</TI_CY>
            <TI_TOWN>Napels</TI_TOWN>
            <TI_TEXT>
               <P>Reagentia en contraststoffen</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="PL">
            <TI_CY>Włochy</TI_CY>
            <TI_TOWN>Neapol</TI_TOWN>
            <TI_TEXT>
               <P>Odczynniki i środki kontrastowe</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="PT">
            <TI_CY>Itália</TI_CY>
            <TI_TOWN>Nápoles</TI_TOWN>
            <TI_TEXT>
               <P>Reagentes e meios de contraste</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="RO">
            <TI_CY>Italia</TI_CY>
            <TI_TOWN>Napoli</TI_TOWN>
            <TI_TEXT>
               <P>Reactivi şi produse de contrast</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SK">
            <TI_CY>Taliansko</TI_CY>
            <TI_TOWN>Neapol</TI_TOWN>
            <TI_TEXT>
               <P>Činidlá a kontrastné médiá</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SL">
            <TI_CY>Italija</TI_CY>
            <TI_TOWN>Neapelj</TI_TOWN>
            <TI_TEXT>
               <P>Reagenti in kontrastna sredstva</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SV">
            <TI_CY>Italien</TI_CY>
            <TI_TOWN>Neapel</TI_TOWN>
            <TI_TEXT>
               <P>Reagens och kontrastmedel</P>
            </TI_TEXT>
         </ML_TI_DOC>
      </ML_TITLES>
      <ML_AA_NAMES>
         <AA_NAME LG="IT">Società Regionale per la Sanità (So.Re.Sa. S.p.A.)</AA_NAME>
      </ML_AA_NAMES>
   </TRANSLATION_SECTION>
   <FORM_SECTION>
      <F03_2014 CATEGORY="ORIGINAL" FORM="F03" LG="IT">
         <CONTRACTING_BODY>
            <ADDRESS_CONTRACTING_BODY>
               <OFFICIALNAME>Società Regionale per la Sanità (So.Re.Sa. S.p.A.)</OFFICIALNAME>
               <ADDRESS>Centro Direzionale Isola F 9</ADDRESS>
               <TOWN>Napoli</TOWN>
               <POSTAL_CODE>80143</POSTAL_CODE>
               <COUNTRY VALUE="IT"/>
               <CONTACT_POINT>Direzione operativa Centrale di Committenza</CONTACT_POINT>
               <PHONE>+39 0812128174</PHONE>
               <E_MAIL>ufficiogare@pec.soresa.it</E_MAIL>
               <FAX>+39 0817500012</FAX>
               <n2016:NUTS CODE="ITF33"/>
               <URL_GENERAL>www.soresa.it</URL_GENERAL>
               <URL_BUYER>http://www.soresa.it</URL_BUYER>
            </ADDRESS_CONTRACTING_BODY>
            <CA_TYPE_OTHER>Centrale di committenza regionale</CA_TYPE_OTHER>
            <CA_ACTIVITY_OTHER>attività di committenza in favore delle aziende sanitarie e amministrazioni aventi sede nel territorio della Regione Campania</CA_ACTIVITY_OTHER>
         </CONTRACTING_BODY>
         <OBJECT_CONTRACT>
            <TITLE>
               <P>Procedura aperta per la conclusione di una convenzione per la fornitura di radiofarmaci per uso diagnostico e terapeutico (kit freddi per marcatura e radiofarmaci) e kit di controllo qualità per le medicine nucleari occorrenti alle/agli ASL/AO/AOU/IRCSS della Regione Campania.</P>
            </TITLE>
            <REFERENCE_NUMBER>6729338</REFERENCE_NUMBER>
            <CPV_MAIN>
               <CPV_CODE CODE="33696000"/>
            </CPV_MAIN>
            <TYPE_CONTRACT CTYPE="SUPPLIES"/>
            <SHORT_DESCR>
               <P>Procedura aperta per la conclusione di una convenzione per la fornitura di radiofarmaci per uso diagnostico e terapeutico (kit freddi per marcatura e radiofarmaci) e kit di controllo qualità per le medicine nucleari occorrenti alle/agli ASL/AO/AOU/IRCSS della Regione Campania.</P>
            </SHORT_DESCR>
            <VAL_TOTAL CURRENCY="EUR">42874315.14</VAL_TOTAL>
            <LOT_DIVISION/>
            <OBJECT_DESCR ITEM="1">
               <TITLE>
                  <P>Generatore di sodio pertecnetato — 10 GBq taratura 7 gg farmaco con AIC.</P>
               </TITLE>
               <LOT_NO>1</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33696000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="IT"/>
               <n2016:NUTS CODE="ITF"/>
               <n2016:NUTS CODE="ITF3"/>
               <SHORT_DESCR>
                  <P>Generatore di sodio pertecnetato — 10 GBq taratura 7 gg farmaco con AIC.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>60</AC_CRITERION>
                  <AC_WEIGHTING>100</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_PRICE>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_PRICE>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="2">
               <TITLE>
                  <P>Generatore di sodio pertecnetato — 15 GBq taratura 7gg farmaco con AIC</P>
               </TITLE>
               <LOT_NO>2</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33696000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ITF3"/>
               <SHORT_DESCR>
                  <P>Generatore di sodio pertecnetato — 15 GBq taratura 7 gg farmaco con AIC.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>60</AC_CRITERION>
                  <AC_WEIGHTING>100</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_PRICE>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_PRICE>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="3">
               <TITLE>
                  <P>Generatore di sodio pertecnetato — 20 GBq taratura 7 gg farmaco con AIC</P>
               </TITLE>
               <LOT_NO>3</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33696000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ITF3"/>
               <SHORT_DESCR>
                  <P>Generatore di sodio pertecnetato — 20 GBq taratura 7 gg farmaco con AIC.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>60</AC_CRITERION>
                  <AC_WEIGHTING>100</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_PRICE>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_PRICE>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="4">
               <TITLE>
                  <P>123 I- Ioflupano soluzione sterile iniettabile suddivisa in consegne di fiale da 185 MBq — Farmaco con AIC</P>
               </TITLE>
               <LOT_NO>4</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33696000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ITF3"/>
               <SHORT_DESCR>
                  <P>123 I- Ioflupano soluzione sterile iniettabile suddivisa in consegne di fiale da 185 MBq — Farmaco con AIC</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="5">
               <TITLE>
                  <P>Iodio 123 soluzione orale 10 mCi/conf (370 MBq)</P>
               </TITLE>
               <LOT_NO>5</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33696000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ITF"/>
               <n2016:NUTS CODE="ITF3"/>
               <SHORT_DESCR>
                  <P>Iodio 123 soluzione orale  10 mCi/conf (370 MBq).</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="6">
               <TITLE>
                  <P>Iodio 123 soluzione iniettabile 1 mCi/conf (37 MBq)</P>
               </TITLE>
               <LOT_NO>6</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33696000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ITF3"/>
               <SHORT_DESCR>
                  <P>Iodio 123 soluzione iniettabile 1 mCi/conf (37 MBq).</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="7">
               <TITLE>
                  <P>Iodio 131 capsule diagnostiche</P>
               </TITLE>
               <LOT_NO>7</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33696000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ITF3"/>
               <SHORT_DESCR>
                  <P>Iodio 131 capsule diagnostiche.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="8">
               <TITLE>
                  <P>Iodio 131 soluzione orale 10 mCi/conf (370 MBq)</P>
               </TITLE>
               <LOT_NO>8</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33696000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ITF3"/>
               <SHORT_DESCR>
                  <P>Iodio 131 soluzione orale 10 mCi/conf (370 MBq).</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="9">
               <TITLE>
                  <P>Iodio 131 soluzione orale 20 mCi/conf (740 MBq)</P>
               </TITLE>
               <LOT_NO>9</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33696000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ITF3"/>
               <SHORT_DESCR>
                  <P>Iodio 131 soluzione orale 20 mCi/conf (740 MBq).</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="10">
               <TITLE>
                  <P>Iodio 131 soluzione orale 30 mCi/conf (1,11 GBq)</P>
               </TITLE>
               <LOT_NO>10</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33696000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ITF3"/>
               <SHORT_DESCR>
                  <P>Iodio 131 soluzione orale 30 mCi/conf (1,11 GBq).</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="11">
               <TITLE>
                  <P>Iodio 131 soluzione orale 50 mCi/conf (1,85 GBq)</P>
               </TITLE>
               <LOT_NO>11</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33696000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ITF3"/>
               <SHORT_DESCR>
                  <P>Iodio 131 soluzione orale 50 mCi/conf (1,85 GBq).</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="12">
               <TITLE>
                  <P>Iodio 131 soluzione sterile 5 mCi/fl (185 MBq)</P>
               </TITLE>
               <LOT_NO>12</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33696000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ITF3"/>
               <SHORT_DESCR>
                  <P>Iodio 131 soluzione sterile 5 mCi/fl (185 MBq).</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="13">
               <TITLE>
                  <P>124 sodio ioduro 15 mCi (555 MBq) soluzione per marcatura farmaci PET — precursore Lotto n.: 13</P>
               </TITLE>
               <LOT_NO>13</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33696000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ITF3"/>
               <SHORT_DESCR>
                  <P>124 sodio ioduro  15 mCi (555 MBq) soluzione per marcatura farmaci PET — precursore</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="14">
               <TITLE>
                  <P>«201 TL-Tallio cloruro soluzione sterile iniettabile in fiale con attività di 111 MBq»</P>
               </TITLE>
               <LOT_NO>14</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33696000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ITF3"/>
               <SHORT_DESCR>
                  <P>«201 TL-Tallio cloruro soluzione sterile iniettabile in fiale con attività di 111 MBq».</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="15">
               <TITLE>
                  <P>111-IN-Octreotide Kit di liofilizzato più soluzione iniettabile di 111 In (122 MBq) taratura almeno 48 ore dopo la data di consegna.</P>
               </TITLE>
               <LOT_NO>15</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33696000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ITF3"/>
               <SHORT_DESCR>
                  <P>111-IN-Octreotide Kit di liofilizzato più soluzione iniettabile di 111 In (122 MBq) taratura almeno 48 ore dopo la data di consegna.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="16">
               <TITLE>
                  <P>«123-I-Meta-Iodio-benzil-guanidina (MIBG) farmaco con AIC soluzione sterile iniettabile fiale da 74 MBq».</P>
               </TITLE>
               <LOT_NO>16</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33696000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ITF3"/>
               <SHORT_DESCR>
                  <P>«123-I-Meta-Iodio-benzil-guanidina (MIBG) farmaco con AIC soluzione sterile iniettabile fiale da 74 MBq».</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="17">
               <TITLE>
                  <P>«123-I-Meta-Iodio-benzil-guanidina (MIBG) farmaco con AIC soluzione sterile iniettabile fiale da 111 MBq»</P>
               </TITLE>
               <LOT_NO>17</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33696000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ITF3"/>
               <SHORT_DESCR>
                  <P>«123-I-Meta-Iodio-benzil-guanidina (MIBG) farmaco con AIC soluzione sterile iniettabile fiale da 111 MBq».</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="18">
               <TITLE>
                  <P>«123-I-Meta-Iodio-benzil-guanidina (MIBG) farmaco con AIC soluzione sterile iniettabile fiale da 185 MBq»</P>
               </TITLE>
               <LOT_NO>18</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33696000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ITF3"/>
               <SHORT_DESCR>
                  <P>«123-I-Meta-Iodio-benzil-guanidina (MIBG) farmaco con AIC soluzione sterile iniettabile fiale da 185 MBq».</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="19">
               <TITLE>
                  <P>Iodio 131 MIBG diagnostico soluzione sterile iniettabile 9,25 MBq/ml — Farmaco con AIC</P>
               </TITLE>
               <LOT_NO>19</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33696000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ITF3"/>
               <SHORT_DESCR>
                  <P>Iodio 131 MIBG diagnostico soluzione sterile iniettabile 9,25 MBq/ml — Farmaco con AIC.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="20">
               <TITLE>
                  <P>Generatore SR-82/RB- 82 — 100 mCi — PET</P>
               </TITLE>
               <LOT_NO>20</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33696000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ITF3"/>
               <SHORT_DESCR>
                  <P>Generatore SR-82/RB- 82 — 100 mCi — PET.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="21">
               <TITLE>
                  <P>Cu 64 per marcature 30 mCi (1,11 GBq) soluzione per marcatura farmaci PET — farmaco con AIC</P>
               </TITLE>
               <LOT_NO>21</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33696000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ITF3"/>
               <SHORT_DESCR>
                  <P>Cu 64 per marcature 30 mCi (1,11 GBq) soluzione per marcatura farmaci PET — farmaco con AIC.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="22">
               <TITLE>
                  <P>FDG (farmaco con AIC) 100-200 mCi (3,7-7,4 GBq) — soluzione iniettabile in fiale multidose-pretaratura</P>
               </TITLE>
               <LOT_NO>22</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33696000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ITF"/>
               <n2016:NUTS CODE="ITF3"/>
               <SHORT_DESCR>
                  <P>FDG (farmaco con AIC) 100-200 mCi (3,7-7,4 GBq) — soluzione iniettabile in fiale multidose-pretaratura.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>60</AC_CRITERION>
                  <AC_WEIGHTING>100</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_PRICE>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_PRICE>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="23">
               <TITLE>
                  <P>FDG (farmaco con AIC) 210-250 mCi (7,70-9,25 GBq) — soluzione iniettabile in fiale multidose</P>
               </TITLE>
               <LOT_NO>23</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33696000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ITF3"/>
               <SHORT_DESCR>
                  <P>FDG (farmaco con AIC) 210-250 mCi (7,70-9,25 GBq) — soluzione iniettabile in fiale multidose.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>60</AC_CRITERION>
                  <AC_WEIGHTING>100</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_PRICE>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_PRICE>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="24">
               <TITLE>
                  <P>FDG (farmaco con AIC) 260-300 mCi (9,62-11,1 GBq) — soluzione iniettabile in fiale multidose pretaratura minima di 30 minuti</P>
               </TITLE>
               <LOT_NO>24</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33696000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ITF3"/>
               <SHORT_DESCR>
                  <P>FDG (farmaco con AIC) 260-300 mCi (9,62-11,1 GBq) — soluzione iniettabile in fiale multidose pretaratura minima di 30 minuti.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>60</AC_CRITERION>
                  <AC_WEIGHTING>100</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_PRICE>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_PRICE>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="25">
               <TITLE>
                  <P>FDG (farmaco con AIC) 310-350 mCi (11,47-12,95 GBq) — Soluzione iniettabile in fiale multidose pretaratura minima di 30 minuti.</P>
               </TITLE>
               <LOT_NO>25</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33696000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ITF3"/>
               <SHORT_DESCR>
                  <P>FDG (farmaco con AIC) 310-350 mCi (11,47-12,95 GBq) — Soluzione iniettabile in fiale multidose pretaratura minima di 30 minuti.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>60</AC_CRITERION>
                  <AC_WEIGHTING>100</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_PRICE>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_PRICE>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="26">
               <TITLE>
                  <P>FDG (farmaco con  AIC) 100-200 mCi (3,7-7,4 GBq) — Soluzione iniettabile in fiale multidose- pretaratura minima di 30 minuti con indicazione nelle patologie infettive o infiammatorie.</P>
               </TITLE>
               <LOT_NO>26</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33696000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ITF3"/>
               <SHORT_DESCR>
                  <P>FDG (farmaco con AIC) 100-200 mCi (3,7-7,4 GBq) — Soluzione iniettabile in fiale multidose- pretaratura minima di 30 minuti con indicazione nelle patologie infettive o infiammatorie.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>60</AC_CRITERION>
                  <AC_WEIGHTING>100</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_PRICE>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_PRICE>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="27">
               <TITLE>
                  <P>«18F-Fluoro-L-dopa PET — diagnosi patologie neurologiche/oncologiche soluzione iniettabile in fiale multidose pretaratura minima di 30 minuti».</P>
               </TITLE>
               <LOT_NO>27</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33696000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ITF3"/>
               <SHORT_DESCR>
                  <P>«18F-Fluoro-L-dopa PET — diagnosi patologie neurologiche/oncologiche soluzione iniettabile in fiale multidose pretaratura minima di 30 minuti».</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>60</AC_CRITERION>
                  <AC_WEIGHTING>100</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_PRICE>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_PRICE>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="28">
               <TITLE>
                  <P>F-18 floruro di sodio  fiale- Diagnostica PET — pretaratura minima di 30 minuti.</P>
               </TITLE>
               <LOT_NO>28</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33696000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ITF3"/>
               <SHORT_DESCR>
                  <P>F-18 floruro di sodio fiale- Diagnostica PET — pretaratura minima di 30 minuti.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>60</AC_CRITERION>
                  <AC_WEIGHTING>100</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_PRICE>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_PRICE>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="29">
               <TITLE>
                  <P>F18- Colina — Soluzione iniettabile in fiale — PET diagnosi tumori a lenta crescita- pretaratura minima di 30 minuti</P>
               </TITLE>
               <LOT_NO>29</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33696000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ITF3"/>
               <SHORT_DESCR>
                  <P>F18- Colina — Soluzione iniettabile in fiale — PET diagnosi tumori a lenta crescita- pretaratura minima di 30 minuti.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>60</AC_CRITERION>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_PRICE>
                  <AC_WEIGHTING>40</AC_WEIGHTING>
               </AC_PRICE>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="30">
               <TITLE>
                  <P>Florbetapir — 18F — PET</P>
               </TITLE>
               <LOT_NO>30</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33696000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ITF3"/>
               <SHORT_DESCR>
                  <P>Florbetapir — 18F — PET.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="31">
               <TITLE>
                  <P>Florbetaben — 18F- PET --300 MBq/ML</P>
               </TITLE>
               <LOT_NO>31</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33696000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ITF3"/>
               <SHORT_DESCR>
                  <P>Florbetaben — 18F- PET --300 MBq/ML.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="32">
               <TITLE>
                  <P>Flutemetamol — 18F — PET- 400 MBq/ml</P>
               </TITLE>
               <LOT_NO>32</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33696000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ITF3"/>
               <SHORT_DESCR>
                  <P>Flutemetamol — 18F — PET- 400 MBq/ml.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="33">
               <TITLE>
                  <P>Iodio 131 norcolesterolo  1 mCi soluzione sterile iniettabile in fiale con attività di 37 MBq.</P>
               </TITLE>
               <LOT_NO>33</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33696000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ITF3"/>
               <SHORT_DESCR>
                  <P>Iodio 131 norcolesterolo  1 mCi soluzione sterile iniettabile in fiale con attività di 37 MBq.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="34">
               <TITLE>
                  <P>Generatore Ge68/Ga68 30 mci — PET — farmaco con AIC</P>
               </TITLE>
               <LOT_NO>34</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33696000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ITF3"/>
               <SHORT_DESCR>
                  <P>Generatore Ge68/Ga68 30 mci — PET — farmaco con AIC.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="35">
               <TITLE>
                  <P>Iodio 131 MIBG 100 mCi — per terapia soluzione sterile iniettabile suddivisa in consegne con fiale da 3,7 GBq</P>
               </TITLE>
               <LOT_NO>35</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33696000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ITF3"/>
               <SHORT_DESCR>
                  <P>Iodio 131 MIBG 100 mCi — per terapia soluzione sterile iniettabile suddivisa in consegne con fiale da 3,7 GBq.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="36">
               <TITLE>
                  <P>Ittrio 90 citrato sosp. coll. 5 mCi Soluzione sterile iniettabile di particelle colloidali per sinoviortesi.</P>
               </TITLE>
               <LOT_NO>36</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33696000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ITF3"/>
               <SHORT_DESCR>
                  <P>Ittrio 90 citrato sosp. coll. 5 mCi Soluzione sterile iniettabile di particelle colloidali per sinoviortesi.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="37">
               <TITLE>
                  <P>RE186- renio solfuro colloidale  185 MBq fiale — Caratteristiche corrispondenti alla Farmacopea europea.</P>
               </TITLE>
               <LOT_NO>37</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33696000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ITF3"/>
               <SHORT_DESCR>
                  <P>RE186- renio solfuro colloidale  185 MBq fiale — Caratteristiche corrispondenti alla Farmacopea europea.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="38">
               <TITLE>
                  <P>Stronzio 89 (farmaco con AIC) 4 mCi soluzione sterile iniettabile per terapia palliative delle metastasi ossee in consegne di fiale da 148 MBq</P>
               </TITLE>
               <LOT_NO>38</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33696000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ITF3"/>
               <SHORT_DESCR>
                  <P>Stronzio 89 (farmaco con  AIC) 4 mCi soluzione sterile iniettabile per terapia palliative delle metastasi ossee in consegne di fiale da 148 MBq.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="39">
               <TITLE>
                  <P>Samario 153 lexidronam  (farmaco con AIC) — soluzione sterile iniettabile per terapia palliativa delle metastasi ossee</P>
               </TITLE>
               <LOT_NO>39</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33696000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ITF3"/>
               <SHORT_DESCR>
                  <P>Samario 153 lexidronam (farmaco con AIC) — soluzione sterile iniettabile per terapia palliativa delle metastasi ossee.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="40">
               <TITLE>
                  <P>90Y ittrio cloruro 3,7 GBQ per la radiomarcatura in vitro dell' anticorpo monoclonale IgG1 kappa ricombinante — precursore — farmaco con AIC.</P>
               </TITLE>
               <LOT_NO>40</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33696000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ITF3"/>
               <SHORT_DESCR>
                  <P>90Y ittrio cloruro 3,7 GBQ per la radiomarcatura in vitro dell' anticorpo monoclonale IgG1 kappa ricombinante — precursore — farmaco con  AIC.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="41">
               <TITLE>
                  <P>90Y ittrio cloruro per la radiomarcatura in vitro — precursore.</P>
               </TITLE>
               <LOT_NO>41</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33696000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ITF3"/>
               <SHORT_DESCR>
                  <P>90Y ittrio cloruro per la radiomarcatura in vitro — precursore.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="42">
               <TITLE>
                  <P>Iodio 131 capsule per terapia</P>
               </TITLE>
               <LOT_NO>42</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33696000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ITF3"/>
               <SHORT_DESCR>
                  <P>Iodio 131 capsule per terapia</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="43">
               <TITLE>
                  <P>Iodio 131 capsule per terapia</P>
               </TITLE>
               <LOT_NO>43</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33696000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ITF3"/>
               <SHORT_DESCR>
                  <P>Iodio 131 capsule per terapia</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="44">
               <TITLE>
                  <P>Radio-223ra-dicloruro iniett — 1 100 KBq/ml</P>
               </TITLE>
               <LOT_NO>44</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33696000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ITF3"/>
               <SHORT_DESCR>
                  <P>Radio-223ra-dicloruro iniett — 1 100 KBq/ml.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="45">
               <TITLE>
                  <P>Esametazima (HM-PaO) per la diagnostica neurologica e le marcature cellulari — farmaco con AIC — precursore</P>
               </TITLE>
               <LOT_NO>45</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33696000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ITF3"/>
               <SHORT_DESCR>
                  <P>Esametazima (HM-PaO) per la diagnostica neurologica e le marcature cellulari — farmaco con AIC — precursore.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="46">
               <TITLE>
                  <P>Bicisato (ECD) per la diagnostica neurologica — farmaco con  AIC — precursore</P>
               </TITLE>
               <LOT_NO>46</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33696000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ITF3"/>
               <SHORT_DESCR>
                  <P>Bicisato (ECD) per la diagnostica neurologica — farmaco con AIC — precursore.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="47">
               <TITLE>
                  <P>HMDP (oxinato) fiale — precursore difosfonato per scintigrafia ossea kit. Caratteristiche corrispondenti alla Farmacopea europea</P>
               </TITLE>
               <LOT_NO>47</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33696000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ITF3"/>
               <SHORT_DESCR>
                  <P>HMDP (oxinato) fiale — precursore difosfonato per scintigrafia ossea kit. Caratteristiche corrispondenti alla Farmacopea europea.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="48">
               <TITLE>
                  <P>Kit pirofosfato stannoso — precursore — agente stannoso per marcatura per la marcatura in vivo di eritrociti — diagnosi delle osteogenesi patologiche</P>
               </TITLE>
               <LOT_NO>48</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33696000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ITF3"/>
               <SHORT_DESCR>
                  <P>Kit pirofosfato stannoso — precursore — agente stannoso per marcatura per la marcatura in vivo di eritrociti — diagnosi delle osteogenesi patologiche.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="49">
               <TITLE>
                  <P>Kit DTPA (ac. Dietilentriaminopenta-acetico) per lo studio della funzionalità renale — precursore</P>
               </TITLE>
               <LOT_NO>49</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33696000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ITF3"/>
               <SHORT_DESCR>
                  <P>Kit DTPA (ac. Dietilentriaminopenta-acetico) per lo studio della funzionalità renale — precursore.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="50">
               <TITLE>
                  <P>Kit DMSA (acido dimercaptosuccinico) per lo studio della morfologia renale — precursore lotto</P>
               </TITLE>
               <LOT_NO>50</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33696000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ITF3"/>
               <SHORT_DESCR>
                  <P>Kit DMSA (acido dimercaptosuccinico) per lo studio della morfologia renale — precursore lotto.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="51">
               <TITLE>
                  <P>MAG-3 (Betiatide- Benzoilmercapto — acetiltriglicina) 1,0 mg Kit fornitura gratuita dispecifico bollitore schermato del radiofarmaco</P>
               </TITLE>
               <LOT_NO>51</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33696000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ITF3"/>
               <SHORT_DESCR>
                  <P>MAG-3 (Betiatide- Benzoilmercapto — acetiltriglicina) 1,0 mg Kit fornitura gratuita dispecifico bollitore schermato del radiofarmaco.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="52">
               <TITLE>
                  <P>Mebrofenina (IHDA) per studi epato-biliari — precursore</P>
               </TITLE>
               <LOT_NO>52</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33696000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ITF3"/>
               <SHORT_DESCR>
                  <P>Mebrofenina (IHDA) per studi epato-biliari — precursore.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="53">
               <LOT_NO>53</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33696000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ITF3"/>
               <SHORT_DESCR>
                  <P>Fitato la preparazione di colloide marcato per scintigrafia epato-splenica kit — precursore.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="54">
               <TITLE>
                  <P>Macroaggregati di albumina umana (MAA) per lo studio della perfusione polmonare Kit — precursore</P>
               </TITLE>
               <LOT_NO>54</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33696000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ITF3"/>
               <SHORT_DESCR>
                  <P>Macroaggregati di albumina umana (MAA) per lo studio della perfusione polmonare Kit — precursore.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="55">
               <TITLE>
                  <P>Tetrakis rame tetrafluoroborato per la diagnosi cardiologia (MIBI). Fornitura gratuita di specifico bollitore schermato del radiofarmaco e specifici contenitori schermati — farmaco con  AIC — Precur</P>
               </TITLE>
               <LOT_NO>55</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33696000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ITF3"/>
               <SHORT_DESCR>
                  <P>Tetrakis rame tetrafluoroborato per la diagnosi cardiologia (MIBI). Fornitura gratuita di specifico bollitore schermato del radiofarmaco e specifici contenitori schermati — farmaco con AIC — Precu.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="56">
               <TITLE>
                  <P>Tetrofosmina — farmaco con  AIC — precursore  tetrofosmina per la diagnosi cardiologia</P>
               </TITLE>
               <LOT_NO>56</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33696000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ITF3"/>
               <SHORT_DESCR>
                  <P>Tetrofosmina — farmaco con  AIC — precursore tetrofosmina per la diagnosi cardiologia.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="57">
               <TITLE>
                  <P>albumina umana particelle nanocolloidali 500 mcg — -farmaco con  AIC — precursore</P>
               </TITLE>
               <LOT_NO>57</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33696000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ITF3"/>
               <SHORT_DESCR>
                  <P>albumina umana particelle nanocolloidali 500 mcg — -farmaco con  AIC — precursore.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="58">
               <TITLE>
                  <P>Besilesomab — anticorpo anti leucociti — farmaco con  AIC — precursore </P>
               </TITLE>
               <LOT_NO>58</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33696000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ITF3"/>
               <SHORT_DESCR>
                  <P>Besilesomab  — anticorpo anti leucociti — farmaco con  AIC — precursore .</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="59">
               <TITLE>
                  <P>Sulesomab — farmaco con AIC — frammenti anticorpali anti granulociti per la diagnostica delle infezioni ortopediche — precursore </P>
               </TITLE>
               <LOT_NO>59</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33696000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ITF3"/>
               <SHORT_DESCR>
                  <P>Sulesomab — farmaco con AIC — frammenti anticorpali anti granulociti per la diagnostica delle infezioni ortopediche — precursore.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="60">
               <TITLE>
                  <P>Tecnezio-99mtc-hynic-octreotide/acido etilendiammino diacetico — precursore</P>
               </TITLE>
               <LOT_NO>60</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33696000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ITF3"/>
               <SHORT_DESCR>
                  <P>Tecnezio-99mtc-hynic-octreotide/acido etilendiammino diacetico — precursore.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="61">
               <TITLE>
                  <P>Kit DPD (ac dicarbossi propano difosfonato) kit freddo per la scintigrafia ossea e diagnosi di amiloidosi cardiaca — numero fiale</P>
               </TITLE>
               <LOT_NO>61</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33696000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ITF3"/>
               <SHORT_DESCR>
                  <P>Kit DPD (ac dicarbossi propano difosfonato) kit freddo per la scintigrafia ossea e diagnosi di amiloidosi cardiaca — numero fiale</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="62">
               <TITLE>
                  <P>Ibritumomab tiuxetano — precursore.</P>
               </TITLE>
               <LOT_NO>62</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33696000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ITF3"/>
               <SHORT_DESCR>
                  <P>Ibritumomab tiuxetano — precursore.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="63">
               <TITLE>
                  <P>Kit controlli tetrofosmina</P>
               </TITLE>
               <LOT_NO>63</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33696000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ITF3"/>
               <SHORT_DESCR>
                  <P>Kit controlli tetrofosmina.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>30</AC_CRITERION>
                  <AC_WEIGHTING>100</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_PRICE>
                  <AC_WEIGHTING>70</AC_WEIGHTING>
               </AC_PRICE>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="64">
               <TITLE>
                  <P>Kit controlli  DMSA</P>
               </TITLE>
               <LOT_NO>64</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33696000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ITF3"/>
               <SHORT_DESCR>
                  <P>Kit controlli DMSA</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>30</AC_CRITERION>
                  <AC_WEIGHTING>100</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_PRICE>
                  <AC_WEIGHTING>70</AC_WEIGHTING>
               </AC_PRICE>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="65">
               <TITLE>
                  <P>Kit controlli  HDP/MDP/pirofosfato</P>
               </TITLE>
               <LOT_NO>65</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33696000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ITF3"/>
               <SHORT_DESCR>
                  <P>Kit controlli HDP/MDP/pirofosfato.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>30</AC_CRITERION>
                  <AC_WEIGHTING>100</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_PRICE>
                  <AC_WEIGHTING>70</AC_WEIGHTING>
               </AC_PRICE>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="66">
               <TITLE>
                  <P>Kit controlli  MAG3</P>
               </TITLE>
               <LOT_NO>66</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33696000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ITF3"/>
               <SHORT_DESCR>
                  <P>Kit controlli MAG3.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>30</AC_CRITERION>
                  <AC_WEIGHTING>100</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_PRICE>
                  <AC_WEIGHTING>70</AC_WEIGHTING>
               </AC_PRICE>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="67">
               <TITLE>
                  <P>Kit controlli sestamibi</P>
               </TITLE>
               <LOT_NO>67</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33696000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ITF3"/>
               <SHORT_DESCR>
                  <P>Kit controlli sestamibi</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>30</AC_CRITERION>
                  <AC_WEIGHTING>100</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_PRICE>
                  <AC_WEIGHTING>70</AC_WEIGHTING>
               </AC_PRICE>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="68">
               <TITLE>
                  <P>Kit controlli  DTPA</P>
               </TITLE>
               <LOT_NO>68</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33696000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ITF"/>
               <n2016:NUTS CODE="ITF3"/>
               <SHORT_DESCR>
                  <P>Kit controlli  DTPA.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>30</AC_CRITERION>
                  <AC_WEIGHTING>100</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_PRICE>
                  <AC_WEIGHTING>70</AC_WEIGHTING>
               </AC_PRICE>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="69">
               <TITLE>
                  <P>Kit controlli pertecnetato/ibritumomab</P>
               </TITLE>
               <LOT_NO>69</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33696000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ITF3"/>
               <SHORT_DESCR>
                  <P>Kit controlli pertecnetato/ibritumomab</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>30</AC_CRITERION>
                  <AC_WEIGHTING>100</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_PRICE>
                  <AC_WEIGHTING>70</AC_WEIGHTING>
               </AC_PRICE>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="70">
               <TITLE>
                  <P>Sistema chiuso per la preparazione in sicurezza dei leucociti marcati.</P>
               </TITLE>
               <LOT_NO>70</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33696000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="ITF3"/>
               <SHORT_DESCR>
                  <P>Sistema chiuso per la preparazione in sicurezza dei leucociti marcati.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>30</AC_CRITERION>
                  <AC_WEIGHTING>100</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_PRICE>
                  <AC_WEIGHTING>70</AC_WEIGHTING>
               </AC_PRICE>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
         </OBJECT_CONTRACT>
         <PROCEDURE>
            <PT_OPEN/>
            <NO_CONTRACT_COVERED_GPA/>
            <NOTICE_NUMBER_OJ>2017/S 090-176502</NOTICE_NUMBER_OJ>
         </PROCEDURE>
         <AWARD_CONTRACT ITEM="1">
            <CONTRACT_NO>1</CONTRACT_NO>
            <LOT_NO>1</LOT_NO>
            <TITLE>
               <P>Generatore di sodio pertecnetato — 10 GBq taratura 7 gg farmaco con AIC</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-02-01</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>2</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Iba Molecular Italy S.r.l.</OFFICIALNAME>
                     <TOWN>Milano</TOWN>
                     <COUNTRY VALUE="IT"/>
                     <n2016:NUTS CODE="ITC4C"/>
                  </ADDRESS_CONTRACTOR>
                  <SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">290720.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">276000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="2">
            <CONTRACT_NO>2</CONTRACT_NO>
            <LOT_NO>2</LOT_NO>
            <TITLE>
               <P>Generatore di sodio pertecnetato — 15 GBq taratura 7 gg farmaco con AIC</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-02-01</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>2</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Iba Molecular Italy S.r.l.</OFFICIALNAME>
                     <TOWN>Milano</TOWN>
                     <COUNTRY VALUE="IT"/>
                     <n2016:NUTS CODE="ITC4C"/>
                  </ADDRESS_CONTRACTOR>
                  <SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">622160.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">609840.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="3">
            <CONTRACT_NO>3</CONTRACT_NO>
            <LOT_NO>3</LOT_NO>
            <TITLE>
               <P>Generatore di sodio pertecnetato — 20 GBq taratura 7 gg farmaco con AIC</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-02-01</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>2</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Iba Molecular Italy S.r.l.</OFFICIALNAME>
                     <TOWN>Milano</TOWN>
                     <COUNTRY VALUE="IT"/>
                     <n2016:NUTS CODE="ITC4C"/>
                  </ADDRESS_CONTRACTOR>
                  <SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">1945434.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">1504800.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="4">
            <CONTRACT_NO>4</CONTRACT_NO>
            <LOT_NO>4</LOT_NO>
            <TITLE>
               <P>123 I- Ioflupano soluzione sterile iniettabile suddivisa in consegne di fiale da 185 MBq — farmaco con AIC</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-02-01</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>GE Healthcare S.r.l.</OFFICIALNAME>
                     <TOWN>Milano</TOWN>
                     <COUNTRY VALUE="IT"/>
                     <n2016:NUTS CODE="ITC4C"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">1945434.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">1945740.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="5">
            <CONTRACT_NO>5</CONTRACT_NO>
            <LOT_NO>5</LOT_NO>
            <TITLE>
               <P>Iodio 123 soluzione orale 10 mCi/conf (370 MBq)</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-02-01</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>2</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>GE Healthcare S.r.l.</OFFICIALNAME>
                     <TOWN>Milano</TOWN>
                     <COUNTRY VALUE="IT"/>
                     <n2016:NUTS CODE="ITC4C"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">199920.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">204000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="6">
            <CONTRACT_NO>6</CONTRACT_NO>
            <LOT_NO>6</LOT_NO>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-02-01</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>2</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>GE Healthcare</OFFICIALNAME>
                     <TOWN>Milano</TOWN>
                     <COUNTRY VALUE="IT"/>
                     <n2016:NUTS CODE="ITC4C"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">20160.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">19800.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="7">
            <CONTRACT_NO>7</CONTRACT_NO>
            <LOT_NO>7</LOT_NO>
            <TITLE>
               <P>Iodio 131 caps diagnostiche 30 microCi (1,11 MBq)</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-02-01</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>GE Healthcare S.r.l.</OFFICIALNAME>
                     <TOWN>Milano</TOWN>
                     <COUNTRY VALUE="IT"/>
                     <n2016:NUTS CODE="ITC4C"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">92000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">91880.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="8">
            <LOT_NO>8</LOT_NO>
            <TITLE>
               <P>Iodio 131 soluzione orale 10 mCi/conf (370 MBq)</P>
            </TITLE>
            <NO_AWARDED_CONTRACT>
               <PROCUREMENT_UNSUCCESSFUL/>
            </NO_AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="9">
            <LOT_NO>9</LOT_NO>
            <TITLE>
               <P>Iodio 131 soluzione orale 20 mCi/conf (740 MBq)</P>
            </TITLE>
            <NO_AWARDED_CONTRACT>
               <PROCUREMENT_UNSUCCESSFUL/>
            </NO_AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="10">
            <LOT_NO>10</LOT_NO>
            <TITLE>
               <P>Iodio 131 soluzione orale 30 mCi/conf (1,11 GBq)</P>
            </TITLE>
            <NO_AWARDED_CONTRACT>
               <PROCUREMENT_UNSUCCESSFUL/>
            </NO_AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="11">
            <LOT_NO>11</LOT_NO>
            <TITLE>
               <P>Iodio 131 soluzione orale  50 mCi/conf (1,85 GBq)</P>
            </TITLE>
            <NO_AWARDED_CONTRACT>
               <PROCUREMENT_UNSUCCESSFUL/>
            </NO_AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="12">
            <LOT_NO>12</LOT_NO>
            <TITLE>
               <P>Iodio 131 soluzione sterile 5 mCi/fl (185 MBq)</P>
            </TITLE>
            <NO_AWARDED_CONTRACT>
               <PROCUREMENT_UNSUCCESSFUL/>
            </NO_AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="13">
            <LOT_NO>lotto. 13</LOT_NO>
            <TITLE>
               <P>124 sodio ioduro 15 mCi (555 MBq) soluzione per marcatura farmaci PET — precursore</P>
            </TITLE>
            <NO_AWARDED_CONTRACT>
               <PROCUREMENT_UNSUCCESSFUL/>
            </NO_AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="14">
            <LOT_NO>14</LOT_NO>
            <TITLE>
               <P>201 TL-tallio cloruro soluzione sterile iniettabile in fiale con attività di 111 MBq</P>
            </TITLE>
            <NO_AWARDED_CONTRACT>
               <PROCUREMENT_UNSUCCESSFUL/>
            </NO_AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="15">
            <CONTRACT_NO>8</CONTRACT_NO>
            <LOT_NO>15</LOT_NO>
            <TITLE>
               <P>111-IN-Octreotide kit di liofilizzato più soluzione iniettabile di 111 In (122 MBq) Taratura almeno 48 ore dopo la data di consegna</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-02-01</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Mallinckrodt Radiopharmaceuticals Italia S.p.A.</OFFICIALNAME>
                     <TOWN>Milano</TOWN>
                     <COUNTRY VALUE="IT"/>
                     <n2016:NUTS CODE="ITC4C"/>
                  </ADDRESS_CONTRACTOR>
                  <SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">1557400.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">1555842.60</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="16">
            <CONTRACT_NO>9</CONTRACT_NO>
            <LOT_NO>16</LOT_NO>
            <TITLE>
               <P>123-I-Meta-Iodio-benzil-guanidina (MIBG) farmaco con  AIC soluzione sterile iniettabile fiale da 74 MBq</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-02-01</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>2</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>GE Healthcare S.r.l.</OFFICIALNAME>
                     <TOWN>Milano</TOWN>
                     <COUNTRY VALUE="IT"/>
                     <n2016:NUTS CODE="ITC4C"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">426240.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">417600.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="17">
            <CONTRACT_NO>10</CONTRACT_NO>
            <LOT_NO>17</LOT_NO>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-02-01</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>GE Healthcare S.r.l.</OFFICIALNAME>
                     <TOWN>Milano</TOWN>
                     <COUNTRY VALUE="IT"/>
                     <n2016:NUTS CODE="ITC4C"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">337440.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">330600.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="18">
            <CONTRACT_NO>11</CONTRACT_NO>
            <LOT_NO>18</LOT_NO>
            <TITLE>
               <P>123-I-Meta-Iodio-benzil-guanidina (MIBG) farmaco con  AIC soluzione sterile iniettabile fiale da 185 MBq</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-02-01</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>GE Healthcare</OFFICIALNAME>
                     <TOWN>Milano</TOWN>
                     <COUNTRY VALUE="IT"/>
                     <n2016:NUTS CODE="ITC4C"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">828800.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">812000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="19">
            <CONTRACT_NO>12</CONTRACT_NO>
            <LOT_NO>19</LOT_NO>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-02-01</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>2</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>GE Healthcare</OFFICIALNAME>
                     <TOWN>Milano</TOWN>
                     <COUNTRY VALUE="IT"/>
                     <n2016:NUTS CODE="ITC4C"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">98021.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">97755.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="20">
            <LOT_NO>20</LOT_NO>
            <TITLE>
               <P>Generatore SR-82/RB- 82 — 100 mCi — PET</P>
            </TITLE>
            <NO_AWARDED_CONTRACT>
               <PROCUREMENT_UNSUCCESSFUL/>
            </NO_AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="21">
            <LOT_NO>21</LOT_NO>
            <TITLE>
               <P>Cu 64 per marcature 30 mCi (1,11GBq) soluzione per marcatura farmaci PET — farmaco con AIC</P>
            </TITLE>
            <NO_AWARDED_CONTRACT>
               <PROCUREMENT_UNSUCCESSFUL/>
            </NO_AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="22">
            <CONTRACT_NO>13</CONTRACT_NO>
            <LOT_NO>22</LOT_NO>
            <TITLE>
               <P>FDG (farmaco con  AIC) 100-200 mCi (3,7-7,4 GBq) — Soluzione iniettabile in fiale multidose — pretaratura minima di 30 minuti</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-02-09</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>2</NB_TENDERS_RECEIVED>
               <AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>RTI: Advanced Accelerator Applications S.r.l. - Kemicons</OFFICIALNAME>
                     <TOWN>Pozzilli</TOWN>
                     <COUNTRY VALUE="IT"/>
                     <n2016:NUTS CODE="ITF21"/>
                  </ADDRESS_CONTRACTOR>
                  <SME/>
               </CONTRACTOR>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Kemiconsult</OFFICIALNAME>
                     <TOWN>Castel di Sangro</TOWN>
                     <COUNTRY VALUE="IT"/>
                     <n2016:NUTS CODE="ITF11"/>
                  </ADDRESS_CONTRACTOR>
                  <SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">2937120.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">2928680.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="23">
            <CONTRACT_NO>14</CONTRACT_NO>
            <LOT_NO>23</LOT_NO>
            <TITLE>
               <P>FDG (farmaco con AIC) 210-250 mCi (7,70 - 9,25 GBq) — Soluzione iniettabile in fiale multidose pretaratura minima di 30 minuti</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-02-09</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>2</NB_TENDERS_RECEIVED>
               <AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>RTI: Advanced Accelerator Applications S.r.l. - Kemicons</OFFICIALNAME>
                     <TOWN>Pozzilli</TOWN>
                     <COUNTRY VALUE="IT"/>
                     <n2016:NUTS CODE="ITF21"/>
                  </ADDRESS_CONTRACTOR>
                  <SME/>
               </CONTRACTOR>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Kemiconsult S.r.l.</OFFICIALNAME>
                     <TOWN>Castel di Sangro</TOWN>
                     <COUNTRY VALUE="IT"/>
                     <n2016:NUTS CODE="ITF11"/>
                  </ADDRESS_CONTRACTOR>
                  <SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">836940.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">834535.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="24">
            <CONTRACT_NO>15</CONTRACT_NO>
            <LOT_NO>24</LOT_NO>
            <TITLE>
               <P>FDG (farmaco con AIC) 260-300 mCi (9,62-11,1 GBq) -Soluzione iniettabile in fiale multidose pretaratura minima di 30 minuti</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-02-09</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>2</NB_TENDERS_RECEIVED>
               <AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>RTI: Advanced Accelerator Applications S.r.l. - Kemicons</OFFICIALNAME>
                     <TOWN>Pozzilli</TOWN>
                     <COUNTRY VALUE="IT"/>
                     <n2016:NUTS CODE="ITF21"/>
                  </ADDRESS_CONTRACTOR>
                  <SME/>
               </CONTRACTOR>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Kemiconsult</OFFICIALNAME>
                     <TOWN>Castel di Sangro</TOWN>
                     <COUNTRY VALUE="IT"/>
                     <n2016:NUTS CODE="ITF11"/>
                  </ADDRESS_CONTRACTOR>
                  <SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">1931400.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">1925850.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="25">
            <CONTRACT_NO>16</CONTRACT_NO>
            <LOT_NO>25</LOT_NO>
            <TITLE>
               <P>FDG (farmaco con AIC) 310-350 mCi (11,47 - 12,95 GBq) — Soluzione iniettabile in fiale multidose pretaratura minima di 30 minuti</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-02-09</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>2</NB_TENDERS_RECEIVED>
               <AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>RTI: Advanced Accelerator Applications S.r.l. - Kemicons</OFFICIALNAME>
                     <TOWN>Pozzilli</TOWN>
                     <COUNTRY VALUE="IT"/>
                     <n2016:NUTS CODE="ITF21"/>
                  </ADDRESS_CONTRACTOR>
                  <SME/>
               </CONTRACTOR>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Kemiconsult S.r.l.</OFFICIALNAME>
                     <TOWN>Castel di Sangro</TOWN>
                     <COUNTRY VALUE="IT"/>
                     <n2016:NUTS CODE="ITF11"/>
                  </ADDRESS_CONTRACTOR>
                  <SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">1802640.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">1797460.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="26">
            <CONTRACT_NO>17</CONTRACT_NO>
            <LOT_NO>26</LOT_NO>
            <TITLE>
               <P>FDG (farmaco con AIC) 100-200 mCi (3,7 -7,4 GBq) - Soluzione iniettabile in fiale multidose- pretaratura minima di 30 minuti con indicazione nelle patologie infettive o infiammatorie</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-02-09</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>RTI: Advanced Accelerator Applications S.r.l. - Kemicons</OFFICIALNAME>
                     <TOWN>Pozzilli</TOWN>
                     <COUNTRY VALUE="IT"/>
                     <n2016:NUTS CODE="ITF21"/>
                  </ADDRESS_CONTRACTOR>
                  <SME/>
               </CONTRACTOR>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Kemiconsult</OFFICIALNAME>
                     <TOWN>Castel di Sangro</TOWN>
                     <COUNTRY VALUE="IT"/>
                     <n2016:NUTS CODE="ITF11"/>
                  </ADDRESS_CONTRACTOR>
                  <SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">113308.80</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">112983.20</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="27">
            <CONTRACT_NO>18</CONTRACT_NO>
            <LOT_NO>27</LOT_NO>
            <TITLE>
               <P>18F-Fluoro-L-dopa PET - diagnosi patologie neurologiche/oncologiche - Soluzione iniettabile in fiale multidose pretaratura minima di 30 minuti</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-02-01</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Acom S.r.l.</OFFICIALNAME>
                     <TOWN>Montecosaro</TOWN>
                     <COUNTRY VALUE="IT"/>
                     <n2016:NUTS CODE="ITI33"/>
                  </ADDRESS_CONTRACTOR>
                  <SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">4958280.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">3722437.89</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="28">
            <LOT_NO>28</LOT_NO>
            <TITLE>
               <P>F-18 floruro di sodio fiale — Diagnostica PET — pretaratura minima di 30 minuti</P>
            </TITLE>
            <NO_AWARDED_CONTRACT>
               <PROCUREMENT_UNSUCCESSFUL/>
            </NO_AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="29">
            <CONTRACT_NO>19</CONTRACT_NO>
            <LOT_NO>29</LOT_NO>
            <TITLE>
               <P>F18- Colina - Soluzione iniettabile in fiale — PET diagnosi tumori a lenta crescita — pretaratura minima di 30 minuti</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-02-09</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>RTI: Advanced Accelerator Applications S.r.l. - Kemicons</OFFICIALNAME>
                     <TOWN>Pozzilli</TOWN>
                     <COUNTRY VALUE="IT"/>
                     <n2016:NUTS CODE="ITF21"/>
                  </ADDRESS_CONTRACTOR>
                  <SME/>
               </CONTRACTOR>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Kemiconsult</OFFICIALNAME>
                     <TOWN>Castel di Sangro</TOWN>
                     <COUNTRY VALUE="IT"/>
                     <n2016:NUTS CODE="ITF11"/>
                  </ADDRESS_CONTRACTOR>
                  <SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">9873316.80</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">9844945.20</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="30">
            <LOT_NO>30</LOT_NO>
            <TITLE>
               <P>AMYVID 370 MBq confezione da 800 MBq/ml soluzione iniettabile</P>
            </TITLE>
            <NO_AWARDED_CONTRACT>
               <PROCUREMENT_UNSUCCESSFUL/>
            </NO_AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="31">
            <CONTRACT_NO>20</CONTRACT_NO>
            <LOT_NO>31</LOT_NO>
            <TITLE>
               <P>Florbetaben — 18F — PET — 300 MBq/ml</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-02-01</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Iba Molecular Italy S.r.l.</OFFICIALNAME>
                     <TOWN>Milano</TOWN>
                     <COUNTRY VALUE="IT"/>
                     <n2016:NUTS CODE="ITC4C"/>
                  </ADDRESS_CONTRACTOR>
                  <SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">228960.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">228240.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="32">
            <CONTRACT_NO>21</CONTRACT_NO>
            <LOT_NO>32</LOT_NO>
            <TITLE>
               <P>Flutemetamol — 18F — PET — 400 MBq/ML</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-02-01</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>GE Healthcare</OFFICIALNAME>
                     <TOWN>Milano</TOWN>
                     <COUNTRY VALUE="IT"/>
                     <n2016:NUTS CODE="ITC4C"/>
                  </ADDRESS_CONTRACTOR>
                  <SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">420760.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">228240.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="33">
            <LOT_NO>33</LOT_NO>
            <TITLE>
               <P>Iodio 131 norcolesterolo 1 mCi soluzione sterile iniettabile in fiale con attività di 37 MBq.</P>
            </TITLE>
            <NO_AWARDED_CONTRACT>
               <PROCUREMENT_UNSUCCESSFUL/>
            </NO_AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="34">
            <CONTRACT_NO>34</CONTRACT_NO>
            <LOT_NO>34</LOT_NO>
            <TITLE>
               <P>Generatore Ge68/Ga68 30 mci — PET — farmaco con AIC</P>
            </TITLE>
            <NO_AWARDED_CONTRACT>
               <PROCUREMENT_UNSUCCESSFUL/>
            </NO_AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="35">
            <CONTRACT_NO>22</CONTRACT_NO>
            <LOT_NO>35</LOT_NO>
            <TITLE>
               <P>Iodio 131 MIBG 100 mCi — per terapia soluzione sterile iniettabile suddivisa in consegne con fiale da 3,7 GBq</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-02-02</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>GE Healthcare S.r.l.</OFFICIALNAME>
                     <TOWN>Milano</TOWN>
                     <COUNTRY VALUE="IT"/>
                     <n2016:NUTS CODE="ITC4C"/>
                  </ADDRESS_CONTRACTOR>
                  <SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">28800.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">115072.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="36">
            <CONTRACT_NO>23</CONTRACT_NO>
            <LOT_NO>36</LOT_NO>
            <TITLE>
               <P>Ittrio 90 citrato sosp. coll. 5 mCi soluzione sterile iniettabile di particelle colloidali per sinoviortesi Soluzione suddivisa in co</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-02-01</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Iba Molecular Italy S.r.l.</OFFICIALNAME>
                     <TOWN>Milano</TOWN>
                     <COUNTRY VALUE="IT"/>
                     <n2016:NUTS CODE="ITC4C"/>
                  </ADDRESS_CONTRACTOR>
                  <SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">47450.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">189280.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="37">
            <LOT_NO>37</LOT_NO>
            <TITLE>
               <P>RE186 — renio solfuro colloidale  185 MBq fiale — Caratteristiche corrispondenti alla Farmacopea europea.</P>
            </TITLE>
            <NO_AWARDED_CONTRACT>
               <PROCUREMENT_UNSUCCESSFUL/>
            </NO_AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="38">
            <CONTRACT_NO>24</CONTRACT_NO>
            <LOT_NO>38</LOT_NO>
            <TITLE>
               <P>Stronzio 89 (farmaco co AIC) 4 mCi soluzione sterile iniettabile per terapia palliative delle metastasi ossee in consegne di fiale da 148 MBq</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-02-01</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>GE Healthcare S.r.l.</OFFICIALNAME>
                     <TOWN>Milano</TOWN>
                     <COUNTRY VALUE="IT"/>
                     <n2016:NUTS CODE="ITC4C"/>
                  </ADDRESS_CONTRACTOR>
                  <SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">37684.80</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">37680.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="39">
            <CONTRACT_NO>25</CONTRACT_NO>
            <LOT_NO>39</LOT_NO>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-02-01</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Iba Molecular Italy S.r.l.</OFFICIALNAME>
                     <TOWN>Milano</TOWN>
                     <COUNTRY VALUE="IT"/>
                     <n2016:NUTS CODE="ITC4C"/>
                  </ADDRESS_CONTRACTOR>
                  <SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">122835.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">469463.40</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="40">
            <CONTRACT_NO>26</CONTRACT_NO>
            <LOT_NO>40</LOT_NO>
            <TITLE>
               <P>90Y ittrio cloruro 3,7 GBQ per la radiomarcatura in vitro dell' anticorpo monoclonale IgG1 kappa ricombinante — precursore — farmaco con AIC</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-02-01</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>2</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Campoverde S.r.l.</OFFICIALNAME>
                     <TOWN>Milano</TOWN>
                     <COUNTRY VALUE="IT"/>
                     <n2016:NUTS CODE="ITC4C"/>
                  </ADDRESS_CONTRACTOR>
                  <SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">490440.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">487512.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="41">
            <CONTRACT_NO>27</CONTRACT_NO>
            <LOT_NO>41</LOT_NO>
            <TITLE>
               <P>90Y ittrio cloruro per la radiomarcatura in vitro — precursore</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-02-01</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Campoverde S.r.l.</OFFICIALNAME>
                     <TOWN>Milano</TOWN>
                     <COUNTRY VALUE="IT"/>
                     <n2016:NUTS CODE="ITC4C"/>
                  </ADDRESS_CONTRACTOR>
                  <SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">488400.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">479520.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="42">
            <CONTRACT_NO>28</CONTRACT_NO>
            <LOT_NO>42</LOT_NO>
            <TITLE>
               <P>Iodio 131 caps per terapia</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-02-01</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Mallinckrodt Radiopharmaceuticals Italia S.p.A.</OFFICIALNAME>
                     <TOWN>Milano</TOWN>
                     <COUNTRY VALUE="IT"/>
                     <n2016:NUTS CODE="ITC4C"/>
                  </ADDRESS_CONTRACTOR>
                  <SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">484440.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">473216.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="43">
            <CONTRACT_NO>29</CONTRACT_NO>
            <LOT_NO>43</LOT_NO>
            <TITLE>
               <P>Iodio 131 caps per terapia</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-02-01</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Mallinckrodt Radiopharmaceuticals Italia S.p.A.</OFFICIALNAME>
                     <TOWN>Milano</TOWN>
                     <COUNTRY VALUE="IT"/>
                     <n2016:NUTS CODE="ITC4C"/>
                  </ADDRESS_CONTRACTOR>
                  <SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">762000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">741160.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="44">
            <CONTRACT_NO>30</CONTRACT_NO>
            <LOT_NO>44</LOT_NO>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-02-02</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Bayer S.r.l.</OFFICIALNAME>
                     <TOWN>Milano</TOWN>
                     <COUNTRY VALUE="IT"/>
                     <n2016:NUTS CODE="ITC4C"/>
                  </ADDRESS_CONTRACTOR>
                  <SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">8317632.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">5658854.40</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="45">
            <CONTRACT_NO>31</CONTRACT_NO>
            <LOT_NO>45</LOT_NO>
            <TITLE>
               <P>Esametazima (HM-PaO) per la diagnostica neurologica e le marcature cellulari - farmaco con  AIC — precursore</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-02-01</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>2</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>GE Healthcare S.r.l.</OFFICIALNAME>
                     <TOWN>Milano</TOWN>
                     <COUNTRY VALUE="IT"/>
                     <n2016:NUTS CODE="ITC4C"/>
                  </ADDRESS_CONTRACTOR>
                  <SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">116584.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">77044.24</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="46">
            <CONTRACT_NO>32</CONTRACT_NO>
            <LOT_NO>46</LOT_NO>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-02-01</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>B.S.N. Biological Sales Network S.r.l.</OFFICIALNAME>
                     <TOWN>Castellona</TOWN>
                     <COUNTRY VALUE="IT"/>
                     <n2016:NUTS CODE="ITC4A"/>
                  </ADDRESS_CONTRACTOR>
                  <SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">304440.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">303924.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="47">
            <LOT_NO>47</LOT_NO>
            <TITLE>
               <P>HMDP (oxinato) fiale — precursore difosfonato per scintigrafia ossea kit. Caratteristiche corrispondenti alla Farmacopea europea</P>
            </TITLE>
            <NO_AWARDED_CONTRACT>
               <PROCUREMENT_UNSUCCESSFUL/>
            </NO_AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="48">
            <LOT_NO>48</LOT_NO>
            <TITLE>
               <P>Kit pirofosfato stannoso — precursore — agente stannoso per marcatura per la marcatura in vivo di eritrociti — diagnosi delle osteogenesi patologiche</P>
            </TITLE>
            <NO_AWARDED_CONTRACT>
               <PROCUREMENT_UNSUCCESSFUL/>
            </NO_AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="49">
            <LOT_NO>49</LOT_NO>
            <TITLE>
               <P>Kit DTPA (ac. dietilentriaminopenta-acetico) per lo studio della funzionalità renale — precursore</P>
            </TITLE>
            <NO_AWARDED_CONTRACT>
               <PROCUREMENT_UNSUCCESSFUL/>
            </NO_AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="50">
            <LOT_NO>50</LOT_NO>
            <TITLE>
               <P>Kit DMSA (acido dimercaptosuccinico) per lo studio della morfologia renale — precursore lotto</P>
            </TITLE>
            <NO_AWARDED_CONTRACT>
               <PROCUREMENT_UNSUCCESSFUL/>
            </NO_AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="51">
            <CONTRACT_NO>33</CONTRACT_NO>
            <LOT_NO>51</LOT_NO>
            <TITLE>
               <P>MAG-3 (Betiatide- Benzoilmercapto - acetiltriglicina) 1,0 mg Kit fornitura gratuita dispecifico bollitore schermato del radiofarmaco</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-02-01</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>B.S.N. Biological Sales Network S.r.l.</OFFICIALNAME>
                     <TOWN>Castellona</TOWN>
                     <COUNTRY VALUE="IT"/>
                     <n2016:NUTS CODE="ITC4A"/>
                  </ADDRESS_CONTRACTOR>
                  <SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">46800.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">40352.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="52">
            <CONTRACT_NO>34</CONTRACT_NO>
            <LOT_NO>52</LOT_NO>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-02-01</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>GE Healthcare S.r.l.</OFFICIALNAME>
                     <TOWN>Milano</TOWN>
                     <COUNTRY VALUE="IT"/>
                     <n2016:NUTS CODE="ITC4C"/>
                  </ADDRESS_CONTRACTOR>
                  <SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">28249.88</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">27940.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="53">
            <CONTRACT_NO>35</CONTRACT_NO>
            <LOT_NO>53</LOT_NO>
            <TITLE>
               <P>Fitato la preparazione di colloide marcato per scintigrafia epato-splenica kit — precursore </P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-02-01</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Iba Molecular Italy S.r.l.</OFFICIALNAME>
                     <TOWN>Milano</TOWN>
                     <COUNTRY VALUE="IT"/>
                     <n2016:NUTS CODE="ITC4C"/>
                  </ADDRESS_CONTRACTOR>
                  <SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">90003.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">9000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="54">
            <CONTRACT_NO>36</CONTRACT_NO>
            <LOT_NO>54</LOT_NO>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-02-01</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Mallinckrodt Radiopharmaceuticals Italia S.p.A.</OFFICIALNAME>
                     <TOWN>Milano</TOWN>
                     <COUNTRY VALUE="IT"/>
                     <n2016:NUTS CODE="ITC4C"/>
                  </ADDRESS_CONTRACTOR>
                  <SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">56703.60</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">53056.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="55">
            <CONTRACT_NO>37</CONTRACT_NO>
            <LOT_NO>55</LOT_NO>
            <TITLE>
               <P>Tetrakis rame tetrafluoroborato per la diagnosi cardiologia (MIBI). Fornitura gratuita di specifico bollitore schermato del radiofarmaco e specifici contenitori schermati — farmaco con AIC — precurs</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-02-01</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>4</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Iba Molecular Italy S.r.l.</OFFICIALNAME>
                     <TOWN>Milano</TOWN>
                     <COUNTRY VALUE="IT"/>
                     <n2016:NUTS CODE="ITC4C"/>
                  </ADDRESS_CONTRACTOR>
                  <SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">153640.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">83500.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="56">
            <CONTRACT_NO>38</CONTRACT_NO>
            <LOT_NO>56</LOT_NO>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-02-01</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>GE Healthcare S.r.l.</OFFICIALNAME>
                     <TOWN>Milano</TOWN>
                     <COUNTRY VALUE="IT"/>
                     <n2016:NUTS CODE="ITC4C"/>
                  </ADDRESS_CONTRACTOR>
                  <SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">655200.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">654472.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="57">
            <CONTRACT_NO>39</CONTRACT_NO>
            <LOT_NO>57</LOT_NO>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-02-01</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>3</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>GE Healthcare</OFFICIALNAME>
                     <TOWN>Milano</TOWN>
                     <COUNTRY VALUE="IT"/>
                     <n2016:NUTS CODE="ITC4C"/>
                  </ADDRESS_CONTRACTOR>
                  <SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">173280.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">99549.36</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="58">
            <LOT_NO>58</LOT_NO>
            <TITLE>
               <P>Besilesomab — anticorpo anti leucociti — farmaco con  AIC — precursore</P>
            </TITLE>
            <NO_AWARDED_CONTRACT>
               <PROCUREMENT_UNSUCCESSFUL/>
            </NO_AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="59">
            <CONTRACT_NO>40</CONTRACT_NO>
            <LOT_NO>59</LOT_NO>
            <TITLE>
               <P>Sulesomab — farmaco con AIC — frammenti anticorpali anti granulociti per la diagnostica delle infezioni ortopediche — precursore</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-02-01</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Astrim S.r.l.</OFFICIALNAME>
                     <TOWN>Milano</TOWN>
                     <COUNTRY VALUE="IT"/>
                     <n2016:NUTS CODE="ITC4C"/>
                  </ADDRESS_CONTRACTOR>
                  <SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">140000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">134000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="60">
            <CONTRACT_NO>41</CONTRACT_NO>
            <LOT_NO>60</LOT_NO>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-02-01</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>B.S.N. Biological Sales Network S.r.l.</OFFICIALNAME>
                     <TOWN>Castellona</TOWN>
                     <COUNTRY VALUE="IT"/>
                     <n2016:NUTS CODE="ITC4A"/>
                  </ADDRESS_CONTRACTOR>
                  <SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">390052.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">390000.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="61">
            <LOT_NO>61</LOT_NO>
            <TITLE>
               <P>Kit DPD (ac dicarbossi propano difosfonato) kit freddo per la scintigrafia ossea e diagnosi di amiloidosi cardiaca — numero fiale</P>
            </TITLE>
            <NO_AWARDED_CONTRACT>
               <PROCUREMENT_UNSUCCESSFUL/>
            </NO_AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="62">
            <CONTRACT_NO>42</CONTRACT_NO>
            <LOT_NO>62</LOT_NO>
            <TITLE>
               <P>Ibritumomab tiuxetano — precursore</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-02-01</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Iba Molecular Italy S.r.l.</OFFICIALNAME>
                     <TOWN>Milano</TOWN>
                     <COUNTRY VALUE="IT"/>
                     <n2016:NUTS CODE="ITC4C"/>
                  </ADDRESS_CONTRACTOR>
                  <SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">2166000.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">2165997.60</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="63">
            <CONTRACT_NO>43</CONTRACT_NO>
            <LOT_NO>63</LOT_NO>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-02-01</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Astrim S.r.l.</OFFICIALNAME>
                     <TOWN>Milano</TOWN>
                     <COUNTRY VALUE="IT"/>
                     <n2016:NUTS CODE="ITC4C"/>
                  </ADDRESS_CONTRACTOR>
                  <SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">23140.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">18690.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="64">
            <CONTRACT_NO>44</CONTRACT_NO>
            <LOT_NO>64</LOT_NO>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-02-01</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Astrim S.r.l.</OFFICIALNAME>
                     <TOWN>Milano</TOWN>
                     <COUNTRY VALUE="IT"/>
                     <n2016:NUTS CODE="ITC4C"/>
                  </ADDRESS_CONTRACTOR>
                  <SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">7930.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">6405.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="65">
            <CONTRACT_NO>45</CONTRACT_NO>
            <LOT_NO>65</LOT_NO>
            <TITLE>
               <P>Kit controlli HDP/MDP/pirofosfato</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-02-01</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>2</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Astrim S.r.l.</OFFICIALNAME>
                     <TOWN>Milano</TOWN>
                     <COUNTRY VALUE="IT"/>
                     <n2016:NUTS CODE="ITC4C"/>
                  </ADDRESS_CONTRACTOR>
                  <SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">40192.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">34665.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="66">
            <CONTRACT_NO>46</CONTRACT_NO>
            <LOT_NO>66</LOT_NO>
            <TITLE>
               <P>Kit controlli  MAG3</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-02-01</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Astrim S.r.l.</OFFICIALNAME>
                     <TOWN>Milano</TOWN>
                     <COUNTRY VALUE="IT"/>
                     <n2016:NUTS CODE="ITC4C"/>
                  </ADDRESS_CONTRACTOR>
                  <SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">10944.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">9439.20</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="67">
            <CONTRACT_NO>47</CONTRACT_NO>
            <LOT_NO>67</LOT_NO>
            <TITLE>
               <P>Kit controlli sestamibi</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-02-01</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>2</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Astrim S.r.l.</OFFICIALNAME>
                     <TOWN>Milano</TOWN>
                     <COUNTRY VALUE="IT"/>
                     <n2016:NUTS CODE="ITC4C"/>
                  </ADDRESS_CONTRACTOR>
                  <SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">11600.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">10440.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="68">
            <CONTRACT_NO>48</CONTRACT_NO>
            <LOT_NO>68</LOT_NO>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-02-01</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>2</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>B.S.N. Biological Sales Network s.r.l.</OFFICIALNAME>
                     <TOWN>Castellona</TOWN>
                     <COUNTRY VALUE="IT"/>
                     <n2016:NUTS CODE="ITC4A"/>
                  </ADDRESS_CONTRACTOR>
                  <SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">14586.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">11781.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="69">
            <CONTRACT_NO>49</CONTRACT_NO>
            <LOT_NO>69</LOT_NO>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-02-01</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>2</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>B.S.N. Biological Sales Network s.r.l.</OFFICIALNAME>
                     <TOWN>Castellona</TOWN>
                     <COUNTRY VALUE="IT"/>
                     <n2016:NUTS CODE="ITC4A"/>
                  </ADDRESS_CONTRACTOR>
                  <SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">1540.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">1176.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="70">
            <CONTRACT_NO>50</CONTRACT_NO>
            <LOT_NO>70</LOT_NO>
            <TITLE>
               <P>Sistema chiuso per la preparazione in sicurezza dei leucociti marcati.</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-02-01</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>2</NB_TENDERS_RECEIVED>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>GE Healthcare S.r.l.</OFFICIALNAME>
                     <TOWN>Milano</TOWN>
                     <COUNTRY VALUE="IT"/>
                     <n2016:NUTS CODE="ITC4C"/>
                  </ADDRESS_CONTRACTOR>
                  <SME/>
               </CONTRACTOR>
               <VAL_ESTIMATED_TOTAL CURRENCY="EUR">56700.00</VAL_ESTIMATED_TOTAL>
               <VAL_TOTAL CURRENCY="EUR">46200.00</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <COMPLEMENTARY_INFO>
            <ADDRESS_REVIEW_BODY>
               <OFFICIALNAME>Tribunale Amministrativo Regionale (TAR) della Campania</OFFICIALNAME>
               <ADDRESS>Piazza Municipio</ADDRESS>
               <TOWN>Napoli</TOWN>
               <COUNTRY VALUE="IT"/>
               <URL>https://www.giustizia-amministrativa.it/cdsintra/cdsintra/Organizzazione/Tribunaliamministrativiregionali/napoli/index.html</URL>
            </ADDRESS_REVIEW_BODY>
            <ADDRESS_MEDIATION_BODY>
               <OFFICIALNAME>Ufficio legale di So.Re.Sa S.p.A.</OFFICIALNAME>
               <ADDRESS>Centro Direzionale Isola F9</ADDRESS>
               <TOWN>Napoli</TOWN>
               <COUNTRY VALUE="IT"/>
            </ADDRESS_MEDIATION_BODY>
            <ADDRESS_REVIEW_INFO>
               <OFFICIALNAME>Ufficio Legale di So.Re.Sa.</OFFICIALNAME>
               <ADDRESS>Centro Direzionale Isola F9</ADDRESS>
               <TOWN>Napoli</TOWN>
               <POSTAL_CODE>80143</POSTAL_CODE>
               <COUNTRY VALUE="IT"/>
               <PHONE>+39 0812128174</PHONE>
            </ADDRESS_REVIEW_INFO>
            <DATE_DISPATCH_NOTICE>2018-02-14</DATE_DISPATCH_NOTICE>
         </COMPLEMENTARY_INFO>
      </F03_2014>
   </FORM_SECTION>
</TED_EXPORT>
